Proteomic analysis of the effect of Fuzheng Huayu recipe on Fibrotic liver in rats

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Xie, Hongdong ^a,b   Tao, Yanyan ^a   Lv, Jing ^a   Liu, Ping ^a,c   Liu, Chenghai ^a,c,d  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b TAIZHOU MUNICIPAL HOSPITAL   (China)

^c Shanghai Municipal Education Commission   (China)

^d Shanghai Key Laboratory of Traditional Chinese Clinical Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALDEHYDE DEHYDROGENASE; CHINESE DRUG; DIMETHYLNITROSAMINE; FRUCTOSE BISPHOSPHATE ALDOLASE; FUZHENG HUAYU; HEAT SHOCK PROTEIN 90; LIVER PROTEIN; PROTEOME; S ADENOSYLHOMOCYSTEINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE HERB; CONTROLLED STUDY; DRUG MECHANISM; FIBROGENESIS; LIVER FIBROSIS; LIVER METABOLISM; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RAT; REAL TIME POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 84874525025     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/972863     Document Type: Article

References (40)

1. Bataller R., Brenner D. A., Liver fibrosis. Journal of Clinical Investigation 2005 115 2 209 218 2-s2.0-14944385607 10.1172/JCI200524282 (Pubitemid 40385459)
2. Wallace K., Burt A. D., Wright M. C., Liver fibrosis. Biochemical Journal 2008 411 1 1 18 2-s2.0-41649088605 10.1042/BJ20071570 (Pubitemid 351482341)
3. Friedman S. L., Rockey D. C., Bissell D. M., Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. Hepatology 2007 45 1 242 249 2-s2.0-33846412916 10.1002/hep.21459 (Pubitemid 46144384)
4. Iredale J., Recent developments in targeting liver fibrosis. Clinical Medicine 2008 8 1 29 31 2-s2.0-39149125148 (Pubitemid 351251563)
5. Lotersztajn S., Julien B., Teixeira-Clerc F., Grenard P., Mallat A., Hepatic fibrosis: molecular mechanisms and drug targets. Annual Review of Pharmacology and Toxicology 2005 45 605 628 2-s2.0-13844306623 10.1146/annurev.pharmtox.45.120403.095906 (Pubitemid 40261819)
6. Jia W., Gao W. Y., Yan Y. Q., Wang J., Xu Z. H., Zheng W. J., Xiao P. G., The rediscovery of ancient Chinese herbal formulas. Phytotherapy Research 2004 18 8 681 686 2-s2.0-4944262480 10.1002/ptr.1506 (Pubitemid 39329723)
7. Normile D., Asian medicine. The new face of traditional Chinese medicine. Science 2003 299 5604 188 190 2-s2.0-0037428194 10.1126/science.299.5604.188 (Pubitemid 36125189)
8. Gao M., Deng C., Lin S., Hu F., Tang J., Yao N., Zhang X., Recent developments and contributions from Chinese scientists in multidimensional separations for proteomics and traditional Chinese medicines. Journal of Separation Science 2007 30 6 785 791 2-s2.0-34248366050 10.1002/jssc.200600372 (Pubitemid 46736399)
9. Liu C., Hu Y., Xu L., Liu C., Liu P., Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chinese Medicine 2009 4, article 12
10. Jiang C. M., Liu C., Interference of «resistance-strengthening and stasis-dispersing formula» on activation channel of para-secretion and auto-secretion in hepatic stallate cells. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai 2002 16 51 53
11. Liu C. H., Wang X. L., Liu P., Gu H. T., Hu Y. Y., A study on Fu Zheng Hua Yu Fang and its ingredients on production of collagen in the liver. Journal of Traditional Chinese Medicine 2000 41 620 622
12. Wang X. L., Liu P., Liu C. H., Liu C., Effects of coordination of FZHY decoction on functions of hepatocytes and hepatic satellate cells. World Chinese Journal of Digestology 1999 7 663 665
13. Ji G., Liu P., Hu Y. Y., Hong J. H., Liu C. H., Liu C., Hepatocyte function changes during acute injury by CC14 fumingating and regulation of Fuzhenghuayu decoction serum. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases 1998 8 215 218
14. Hu Y. Y., Liu C., Liu P., Gu H. T., Ji G., Wang X. L., Anti fibrosis and anti peroxidation of lipid effects of Fuzhenghuayu decoction on rat liver induced by CCl4. Chinese Journal of New Gastroenterology 1997 5 485 486
15. Jiang C. M., Liu C., Liu C. H., Hu Y. Y., Effect of Fuzheng Huayu decoction (FZHYF) on the function of Kupffer cells from acute injury liver induced by CCl4. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases 2000 10 26 28
16. Liu P., Hu Y. Y., Liu C., Xu L. M., Liu C. H., Sun K. W., Hu D. C., Yin Y. K., Zhou X. Q., Wan M. B., Cai X., Zhang Z. Q., Ye J., Zhou R. X., He J., Tang B. Z., Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B. World Journal of Gastroenterology 2005 11 19 2892 2899 2-s2.0-20344397684 (Pubitemid 40790056)
17. Ala-Kokko L., Pihlajaniemi T., Myers J. C., Kivirikko K. I., Savolainen E. R., Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochemical Journal 1987 244 1 75 79 2-s2.0-0023196358 (Pubitemid 17098811)
18. Yu L. R., Shao X. X., Jiang W. L., Xu D., Chang Y. C., Xu Y. H., Xia Q. C., Proteome alterations in human hepatoma cells transfected with antisense epidermal growth factor receptor sequence. Electrophoresis 2001 22 14 3001 3008 10.1002/1522-2683(200108)22:14<3001::AID-ELPS3001>3.0.CO;2-5
19. Yu L. R., Zeng R., Shao X. X., Wang N., Xu Y. H., Xia Q. C., Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 2000 21 14 3058 3068 10.1002/1522-2683(20000801)21:14<3058::AID-ELPS3058>3.0.CO;2-U
20. Wynn T. A., Cellular and molecular mechanisms of fibrosis. Journal of Pathology 2008 214 2 199 210 2-s2.0-38549159026 10.1002/path.2277 (Pubitemid 351160157)
21. Kristensen D. B., Kawada N., Imamura K., Miyamoto Y., Tateno C., Seki S., Kuroki T., Yoshizato K., Proteome analysis of rat hepatic stellate cells. Hepatology 2000 32 2 268 277 2-s2.0-0033866513 (Pubitemid 30614659)
22. Kawada N., Kristensen D. B., Asahina K., Nakatani K., Minamiyama Y., Seki S., Yoshizato K., Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cells. Journal of Biological Chemistry 2001 276 27 25318 25323 2-s2.0-0035816696 10.1074/jbc.M102630200
23. Petrak J., Myslivcova D., Man P., Cmejla R., Cmejlova J., Vyoral D., Proteomic analysis of iron overload in human hepatoma cells. American Journal of Physiology 2006 290 5 G1059 G1066 2-s2.0-33645813628 10.1152/ajpgi.00469.2005
24. Jacobs J. M., Diamond D. L., Chan E. Y., Gritsenko M. A., Qian W., Stastna M., Baas T., Camp D. G., Carithers R. L., Smith R. D., Katze M. G., Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients. Journal of Virology 2005 79 12 7558 7569 2-s2.0-19944419128 10.1128/JVI.79.12.7558-7569.2005 (Pubitemid 40756791)
25. Diamond D. L., Jacobs J. M., Paeper B., Proll S. C., Gritsenko M. A., Carithers R. L., Larson A. M., Yeh M. M., Camp D. G., Smith R. D., Katze M. G., Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction. Hepatology 2007 46 3 649 657 2-s2.0-34548788465 10.1002/hep.21751 (Pubitemid 47436109)
26. Liu E. H., Chen M. F., Yeh T. S., Ho Y. P., Wu R. C., Chen T. C., Jan Y. Y., Pan T. L., A useful model to audit liver resolution from cirrhosis in rats using functional proteomics. Journal of Surgical Research 2007 138 2 214 223 2-s2.0-33847660139 10.1016/j.jss.2005.09.022 (Pubitemid 46365715)
27. Henkel C., Roderfeld M., Weiskirchen R., Scheibe B., Matern S., Roeb E., Identification of fibrosis-relevant proteins using DIGE (difference in gel electrophoresis) in different models of hepatic fibrosis. Zeitschrift fur Gastroenterologie 2005 43 1 23 29 2-s2.0-12944291468 10.1055/s-2004-813911 (Pubitemid 40175388)
28. Ichibangase T., Moriya K., Koike K., Imai K., A proteomics method revealing disease-related proteins in livers of hepatitis-infected mouse model. Journal of Proteome Research 2007 6 7 2841 2849 2-s2.0-34547149582 10.1021/pr070094c (Pubitemid 47122378)
29. Miliani S., Herbst H., Schuppan D., Niedobitek G., Kim K. Y., Stein H., Vimentin expression of newly formed rat bile duct epithelial cells in secondary biliary fibrosis. Virchows Archiv. A, Pathological Anatomy and Histopathology 1989 415 3 237 242 2-s2.0-0024386758 (Pubitemid 19192556)
30. Parola M., Robino G., Oxidative stress-related molecules and liver fibrosis. Journal of Hepatology 2001 35 2 297 306 2-s2.0-0034869459 10.1016/S0168-8278(01)00142-8 (Pubitemid 32803489)
31. Harrison D. J., May L., Hayes P. C., Haque M. M., Hayes J. D., Glutathione S-transferases in alcoholic liver disease. Gut 1990 31 8 909 912 2-s2.0-0025033321 (Pubitemid 20269541)
32. Yamaguchi M., Isogai M., Shimada N., Potential sensitivity of hepatic specific protein regucalcin as a marker of chronic liver injury. Molecular and Cellular Biochemistry 1997 167 1-2 187 190 2-s2.0-0031043374 10.1023/A:1006859121897 (Pubitemid 27081347)
33. Yamaguchi M., Tsurusaki Y., Misawa H., Inagaki S., Ma Z. J., Takahashi H., Potential role of regucalcin as a specific biochemical marker of chronic liver injury with carbon tetrachloride administration in rats. Molecular and Cellular Biochemistry 2002 241 1-2 61 67 2-s2.0-0036893319 10.1023/A: 1020822610085 (Pubitemid 35385835)
34. Lv S., Wang J. H., Liu F., Gao Y., Fei R., Du S. C., Wei L., Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay. BMC Gastroenterology 2008 8, article 17 2-s2.0-46349100710 10.1186/1471-230X-8-17 (Pubitemid 351917266)
35. Ivaska J., Pallari H. M., Nevo J., Eriksson J. E., Novel functions of vimentin in cell adhesion, migration, and signaling. Experimental Cell Research 2007 313 10 2050 2062 2-s2.0-34249682108 10.1016/j.yexcr.2007.03.040 (Pubitemid 46842979)
36. Nakatsuji S., Yamate J., Sakuma S., Relationship between vimentin expressing renal tubules and interstitial fibrosis in chronic progressive nephropathy in aged rats. Virchows Archiv 1998 433 4 359 367 2-s2.0-0031672117 10.1007/s004280050260 (Pubitemid 28477037)
37. Meindl-Beinker N. M., Dooley S., Transforming growth factor- β and hepatocyte transdifferentiation in liver fibrogenesis. Journal of Gastroenterology and Hepatology 2008 23 supplement 1 S122 S127 2-s2.0-40749086831 10.1111/j.1440-1746.2007.05297.x (Pubitemid 351389043)
38. Geerts A., Eliasson C., Niki T., Wielant A., Vaeyens F., Pekny M., Formation of normal desmin intermediate filaments in mouse hepatic stellate cells requires vimentin. Hepatology 2001 33 1 177 188 2-s2.0-0035200752 10.1053/jhep.2001.21045 (Pubitemid 32016900)
39. Liu Y., Liu P., Hu Y. Y., Xu L., Wang L., Mu Y., Du G., Dynamic change of metabolism related protein in liver tissue of rats' model of hepatic fibrosis and regulatory effect of fuzheng huayu decoction on it. Chinese Journal of Integrated Traditional and Western Medicine 2006 26 3 224 227 2-s2.0-34447564413
40. Qian W. J., Jacobs J. M., Liu T., Camp D. G., Smith R. D., Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Molecular and Cellular Proteomics 2006 5 10 1727 1744 2-s2.0-33750728385 10.1074/mcp.M600162-MCP200 (Pubitemid 44696109)